VXRT logo

Vaxart (VXRT) Company Overview

Profile

Full Name:

Vaxart, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

December 11, 1981

Indexes:

Not included

Description:

Vaxart (VXRT) is a biotechnology company focused on developing oral vaccines using its unique tablet technology. The company aims to create effective vaccines for various diseases, including COVID-19 and norovirus, to improve public health and provide easier vaccination options.

Key Details

Price

$0.46

Annual Revenue

$7.38 M(+6796.26% YoY)

Annual EPS

-$0.57(+32.14% YoY)

Annual ROE

-97.94%

Beta

2.10

Events Calendar

Earnings

Next earnings date:

Mar 14, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

Mar 14, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Nov 9, 2012
Splits

Next split:

N/A

Recent split:

Feb 14, 2018

Analyst ratings

Recent major analysts updates

Aug 15, 24 Oppenheimer
Outperform
Jan 31, 24 B. Riley Securities
Buy
Sep 7, 23 Cantor Fitzgerald
Overweight
Aug 7, 23 Cantor Fitzgerald
Overweight
Dec 19, 22 B. Riley Securities
Neutral
Sep 2, 22 Cantor Fitzgerald
Overweight
May 19, 22 B. Riley Securities
Neutral
Nov 2, 21 Cantor Fitzgerald
Overweight
Jun 30, 21 B. Riley Securities
Neutral
Jun 24, 21 Jefferies
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Dividend per share

Dividend yield

Other

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Vaxart?
  • Does Vaxart pay dividends?
  • What sector is Vaxart in?
  • What industry is Vaxart in?
  • What country is Vaxart based in?
  • When did Vaxart go public?
  • Is Vaxart in the S&P 500?
  • Is Vaxart in the NASDAQ 100?
  • Is Vaxart in the Dow Jones?
  • When was Vaxart's last earnings report?
  • When does Vaxart report earnings?
  • Should I buy Vaxart stock now?

What is the ticker symbol for Vaxart?

The ticker symbol for Vaxart is NASDAQ:VXRT

Does Vaxart pay dividends?

No, Vaxart does not pay dividends

What sector is Vaxart in?

Vaxart is in the Healthcare sector

What industry is Vaxart in?

Vaxart is in the Biotechnology industry

What country is Vaxart based in?

Vaxart is headquartered in United States

When did Vaxart go public?

Vaxart's initial public offering (IPO) was on December 11, 1981

Is Vaxart in the S&P 500?

No, Vaxart is not included in the S&P 500 index

Is Vaxart in the NASDAQ 100?

No, Vaxart is not included in the NASDAQ 100 index

Is Vaxart in the Dow Jones?

No, Vaxart is not included in the Dow Jones index

When was Vaxart's last earnings report?

Vaxart's most recent earnings report was on Nov 13, 2024

When does Vaxart report earnings?

The next expected earnings date for Vaxart is Mar 14, 2025

Should I buy Vaxart stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions